Posted by Michael Wonder on 11 Jul 2022
Drug Utilisation SubCommittee outcome statement
8 July 2022 - The outcome statement from the June 2022 DUSC meeting is now available.
The DUSC reviewed the utilisation of the following PBS medicines in June 2022:
- Teduglutide - type III (chronic) intestinal failure associated with short bowel syndrome
- Proton pump inhibitors - gastro-intestinal acid related disorders
Read DUSC outcome statement
Posted by:
Michael Wonder